Remove 2024 Remove Communication Remove Packaging
article thumbnail

Navigating the regulatory challenge of PFAS for pharmaceutical manufacturers

European Pharmaceutical Review

These chemicals are everywhere and have been used in many ways over the decades, bringing a range of benefits from water- and stain-resistant coatings and firefighting foams to nail polish and food packaging. However, the world is now learning they are also persistent pollutants that contaminate our soil, water and air. CHEM Trust.

article thumbnail

DSCSA Postponement And What It Means For Independent Pharmacies

DiversifyRx

Small Dispensers and the 6/12/2024 FDA Announcement Concerning DSCSA This week’s article on the recent DSCSA postponement comes from PRS Pharmacy Services. Not All Pharmacies Can Exempt from The 11/27/2024 DSCSA Requirements. The original article can be found HERE. The DSCSA Adventure continues. The DSCSA Adventure continues.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

DSCSA Compliance for Independent Pharmacies

DiversifyRx

While DSCSA (the Drug Supply Chain Security Act) enforcement is postponed until November 2024, it is critical to move forward in becoming compliant sooner rather than later. This tracking involves the use of unique product identifiers, such as serial numbers and barcodes, on drug packaging to track their movement.

article thumbnail

Learning Clinical Microbiology Using Podcasting: The Let’s Talk Micro Podcast

IDStewardship

In 2021 I enrolled in a Master’s for Microbiology and cell science at the University of Florida and I am expecting to complete it in December of 2024. Not being afraid to communicate with people has been important to my success. I think that is where I do my best work I. I have found a lot of my guests through social media.

article thumbnail

Pharmacy practice in emergency care: patient safeguarding

Hospital Pharmacy Europe

In 2023, the Royal College of Emergency Medicine and the UK Clinical Pharmacy Association recommended all EDs have a dedicated pharmacist and, as of 2024, approximately 77 of 170 UK EDs (45%) have a clinical pharmacy service. Pharm J; 26 March 2024. Accessed June 2024]. Greenwood D et al. Int J Clin Pharm 2019;41:434–44.

article thumbnail

Piloting the PQA Specialty Pharmacy Turnaround Time Quality Measure

PQA

Pilot participants were provided a technical package containing all resources needed to accurately calculate the SP-TAT-PH measure. For example, one participant described how varying levels of “urgency” could be communicated to pharmacists, empowering them to prioritize prescriptions for expedited review. on October 8, at 4:30 p.m.

article thumbnail

Clinical trials for rare diseases

European Pharmaceutical Review

FDA is expected to provide initial feedback on the data submitted by July 2024, with further data to be collected and analysed over the next two years. How does the qualification package support more meaningful endpoints and rare disease research as a result?

FDA 52